RefloDx

RefloDx, founded with the mission to revolutionize diagnostic tools for reflux detection, focuses on providing non-invasive solutions for early identification and characterization of reflux events. Their flagship product, SondeFlux™, is a patented ultrasound-based device designed to detect Laryngopharyngeal Reflux (LPR) in a home setting. By offering standardized and objective evidence that correlates symptoms with LPR, RefloDx aims to improve patient outcomes and advance the diagnostic testing market.

Notable affiliated individuals and investors have yet to be publicly disclosed, but the company's innovative approach has already marked significant achievements. The development of SondeFlux™ represents a major advancement in non-invasive diagnostic technology, potentially reducing the need for more invasive procedures. RefloDx's impact lies in its potential to provide better diagnostics, thereby improving lives through early and accurate detection of reflux conditions.